|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | |||||||||||
| Other current assets | |||||||||||
| Deposit | |||||||||||
| TOTAL CURRENT ASSETS | |||||||||||
| Royalty Interests | |||||||||||
| Other Assets | |||||||||||
| NON CURRENT ASSETS | |||||||||||
| Deposit | |||||||||||
| TOTAL NON CURRENT ASSETS | |||||||||||
| TOTAL ASSETS | |||||||||||
| LIABILITIES | |||||||||||
| Current Liabilities: | |||||||||||
| Due to Director | |||||||||||
| Note Payable - Related Party | |||||||||||
| Loan - Related Party | |||||||||||
| Account Payable | |||||||||||
| Income Tax Payable | |||||||||||
| Interest Payable | |||||||||||
| Accrued Liabilities | |||||||||||
| TOTAL LIABILITIES | |||||||||||
| COMMITMENTS AND CONTINGENCIES | |||||||||||
| Preferred Stock: authorized 20,000,000, $0.001 par value | |||||||||||
| Preferred Stock: authorized 20,000,000, $0.001 par value | |||||||||||
| Common Stock: authorized 180,000,000, $0.001 par value | |||||||||||
| Issued and outstanding shares : 20,155,300 at September 30, 2023 and 20,155,300 at Dec 31, 2022* | |||||||||||
| Additional Paid-in Capital | |||||||||||
| Subscription Receivable | |||||||||||
| Accumulated Deficit | |||||||||||
| Total Stockholders' Equity | |||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
